Pulmonary embolism@[email protected]
Click here to load reader
-
Upload
islam-ghanem -
Category
Education
-
view
2.362 -
download
0
Transcript of Pulmonary embolism@[email protected]
![Page 1: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/1.jpg)
Islam GhanemMSC Cardiology
2013
Pulmonary Embolism
![Page 2: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/2.jpg)
سورة التوبة )األية 105)
![Page 3: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/3.jpg)
3
![Page 4: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/4.jpg)
DefinitionIntroductionPathophysiologyClinical Features InvestigationsTreatmentPulmonary embolism in pregnancyPrognosisHome Message
![Page 5: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/5.jpg)
Definition
![Page 6: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/6.jpg)
Pulmonary Embolus is a fragment of thethrombus that breaks off and travels inthe blood until it lodges at the pulmonary vasculature.
Exogenous or endogenous material (usually a venous thrombus) travelling to lungs (via the venous circulation)
![Page 7: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/7.jpg)
Introduction
![Page 8: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/8.jpg)
Acute PE is a relatively common cardiovascular emergency.
High mortality rate if left untreatedClinical presentation is highly variable and
non-specificDiagnosis requires appropriate and
accurate imagingPrompt diagnosis and treatment can
reduce mortality from 30% to 2-8%
![Page 9: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/9.jpg)
Highest incidence in hospitalized patients
Autopsy reports suggest it is commonly “missed” diagnosed
A Common disorder and potentially deadly
The incidence of PE in USA is 500,000 per year50,000 individuals die from PE each year in USA
![Page 10: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/10.jpg)
90-95% of pulmonary emboli originate
in the deep venous system of the lower extremities
Other rare locations include
Uterine and prostatic veins
Upper extremities
Renal veins
Right side of the heart
![Page 11: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/11.jpg)
Pathophysiology
![Page 12: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/12.jpg)
Rudolph Virchow, 1858
Triad: Hypercoagulability Stasis to flow
Vessel injury
Rudolf Virchow postulated more than a century ago that a triad of factors predisposed to venous thrombosis
![Page 13: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/13.jpg)
Know something about a great scientist who gave us a lot in VTE-------Rudolph
Virchow
![Page 14: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/14.jpg)
Born in Pomerania 1821graduated in medicine 1843presented work on thrombosis 1845
but could not get it publishedfounded own journal
Rudolf Virchow
![Page 15: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/15.jpg)
This is the first page of the original manuscript,
which consists of this narrative introduction
entitled “Wichtigste Arbeiten” followed by
the chronological outline. Ackerknecht in
his biography of Virchow called the
manuscript a curriculum vitae. The
form of the manuscript however is more akin to
a simple autobiographical piece of work. Virchow used
one single sheet of 81/2” by 11” paper that was folded in half with
the “Most Important Works” as the front
cover and the inside right half of the page
and the reverse of that right half of the page
containing the chronological outline.
![Page 16: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/16.jpg)
Appointed Professor of Pathology in Wurzburg
Described leukaemia, pulmonary embolism and much more
1856 appointed Professor of Pathology in Berlin despite government opposition
Rudolf Virchow
![Page 17: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/17.jpg)
1858 published ‘Cellular Pathology’ one of the most influential medical books ever written
Died aged 81 after fracturing his hip jumping from a moving tram
Rudolf Virchow
![Page 18: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/18.jpg)
HypercoagulabilityMalignancyNonmalignant thrombophilia
PregnancyPostpartum status (<4wk)Estrogen/ OCP’s Genetic mutations (Factor V Leiden,
Protein C & S deficiency, Prothrombin mutations, anti-thrombin III deficiency, antiphospholipid syndrome)
Mutation of Factor V Leiden rendering factor V resistant to inactivation by activated protein C is the most common congenital coagulopathy
![Page 19: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/19.jpg)
Venous StatisBedrest > 24 hr Recent cast or external fixatorLong-distance travel or prolong automobile
travel
Venous InjuryRecent surgery requiring endotracheal
intubationRecent trauma (especially the lower extremities
and pelvis)
![Page 20: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/20.jpg)
Modifiable : Obesity
Metabolic syndrome Cigarette smoking Hypertension Abnormal lipid profile High consumption of red meat and low consumption of fish, fruits, and vegetables
Risk Factors
![Page 21: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/21.jpg)
Non Modifiable : Advancing age
Arterial disease, including carotid and coronary disease Personal or family history of venous thromboembolism Recent surgery, trauma, or immobility, including stroke Congestive heart failure (So in AHF , prophylaxis is indicated) Chronic obstructive pulmonary disease Acute infection Air pollution Long-haul air travel Pregnancy, oral contraceptive pills, or postmenopausal hormone replacement therapy Pacemaker, implantable cardiac defibrillator leads, or indwelling central venous catheter
![Page 22: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/22.jpg)
The risk of fatal PE in this setting is less than 1 in 1 million.
Activation of the coagulation system during air travel.
For each 2-hour increase in travel duration, there appears to be an 18% higher risk of VTE.
Air travel & Risk of PE
![Page 23: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/23.jpg)
Increased pulmonary vascular resistanceImpaired gas exchange Alveolar hyperventilationIncreased airway resistanceDecreased pulmonary compliance
Pathophysiology
![Page 24: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/24.jpg)
More than 50% of the vascular bed has to be occluded before PAP becomes substantially elevated
When obstruction approaches 75%, the RV must generate systolic pressure in excess of 50mmHg to preserve pulmonary circulation
The normal RV is unable to accomplish this acutely and eventually fails
![Page 25: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/25.jpg)
![Page 26: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/26.jpg)
Clinical Features
![Page 27: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/27.jpg)
Symptoms in Patients with Angio Proven PTE
SymptomPercent
Dyspnea84Chest Pain, pleuritic74
Anxiety59Cough53
Hemoptysis30Sweating27
Chest Pain, nonpleuritic14Syncope13
![Page 28: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/28.jpg)
Symptoms in Patients with Angio Proven PTE
SymptomPercent
Dyspnea84Chest Pain, pleuritic74
Anxiety59Cough53
Hemoptysis30Sweating27
Chest Pain, nonpleuritic14Syncope13
![Page 29: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/29.jpg)
Signs with Angiographically Proven PE
SignPercent
Tachypnea > 20/min92Rales58
Accentuated S253Tachycardia >100/min44
Fever > 37.843Diaphoresis36
S3 or S4 gallop34 Thrombophebitis32
Lower extremity edema24
![Page 30: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/30.jpg)
Signs with Angiographically Proven PE
SignPercent
Tachypnea > 20/min92Rales58
Accentuated S253Tachycardia >100/min44
Fever > 37.843Diaphoresis36
S3 or S4 gallop34 Thrombophebitis32
Lower extremity edema24
![Page 31: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/31.jpg)
Hypotension + elevated JVP + distant H.S or clear back
In
triad Beck’sPul
monar
y
emboli
sm
RV i
nfarction
Peri
car
di
al t
amponade
Tension
pneumothorax
![Page 32: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/32.jpg)
Investigations
![Page 33: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/33.jpg)
Imaging Studies CXR V/Q Scans Spiral Chest CT Pulmonary Angiography Echocardiograpy
Laboratory Analysis CBC, ESR, Hgb/Hct, D-Dimer ABG’s
Ancillary Testing EKG Pulse Oximetry
Diagnostic Test
![Page 34: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/34.jpg)
Chest X-Ray Myth:
“We have to do a chest x-ray so we can find Hampton’s hump or a Westermark sign.”
Reality:
Most chest x-rays in patients with PE are nonspecific and insensitive
Normal CXR in setting of severe respiratory distress Think of
Diagnostic Testing- CXR’s
Pulmonary embolism
![Page 35: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/35.jpg)
Chest X-ray Eponyms of PEHampton’s Hump –
consists of a pleura based shallow wedge-shaped
consolidation in the lung periphery with the base against the
pleural surface.
![Page 36: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/36.jpg)
36
Chest radiograph showing pulmonary infarct in right lower lobe
![Page 37: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/37.jpg)
Peripheral right pulmonary embolus
Hampton ’s Hump causing elevated hemi- diaphragm
![Page 38: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/38.jpg)
Chest X-ray Eponyms of PEWestermark sign –
Dilatation of pulmonary vessels
proximal to embolism along with
collapse of distal vessels, often with a
sharp cut off.
Pruning))
![Page 39: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/39.jpg)
Radiographic Eponyms- Hampton’s Hump, Westermark’s Sign
Westermark’s Sign
Hampton’s Hump
![Page 40: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/40.jpg)
-Palla’s sign: dilated descending right The vessel often tapers rapidly after the enlarged
portion pulmonary artery.
![Page 41: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/41.jpg)
o A common modality to image the lung and its use still stems.
o Relatively noninvasive and sadly most often non diagnostic
o In many centers remains the initial test of choice
o Preferred test in pregnant patientso 50 mrem vs 800mrem (with spiral CT)o Less radiation exposure to the mother, but more to
the foetus
Ventilation/Perfusion Scan- “V/Q Scan”
![Page 42: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/42.jpg)
Only three indications to obtain a lung scan exist: (1) renal insufficiency, (2) anaphylaxis to intravenous contrast agent that cannot be suppressed with high-dose corticosteroids (3) pregnancy (lower radiation exposure to the mother).High probability scan: If 2 or more segmental perfusion defects with normal ventilation
![Page 43: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/43.jpg)
TechniqueV/Q Scan
![Page 44: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/44.jpg)
![Page 45: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/45.jpg)
High-probability ventilation-perfusion scan
![Page 46: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/46.jpg)
Major advantage of Spiral CT is speed: Often the patient can hold their breath for the
entire study, reducing motion artifacts. Allows for more optimal use of intravenous
contrast enhancement. Spiral CT is quicker than the equivalent
conventional CT permitting the use of higher resolution acquisitions in the same study time.
Contraindicated in cases of renal disease. Sensitive for PE in the proximal pulmonary
arteries, but less so in the distal segments.
Spiral CT
![Page 47: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/47.jpg)
Quickly becoming the test of choice for initial evaluation of a suspected PE.
CT unlikely to miss any lesion.CT has better sensitivity, specificity and can
be used directly to screen for PE.CT can be used to follow up “non diagnostic
V/Q scans.
CT Angiogram
![Page 48: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/48.jpg)
CT AngiogramChest computed tomography scanning demonstrating extensive embolization
of the pulmonary arteries.
![Page 49: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/49.jpg)
Size, location, and extent of thrombus Other diagnoses that may coexist with PE or explain PE symptoms:
Pneumonia Atelectasis Pericardial effusion Pneumothorax Left ventricular enlargement
Pulmonary artery enlargement, suggestive of pulmonary hypertension
Age of thrombus: acute, subacute, chronic
Location of thrombus: pulmonary arteries, pelvic veins, deep leg veins, upper extremity veins
Right ventricular enlargement
Contour of the interventricular septum: whether it bulges toward the left ventricle, thus indicating right ventricular pressure overload
Incidental masses or nodules in lung
![Page 50: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/50.jpg)
![Page 51: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/51.jpg)
![Page 52: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/52.jpg)
![Page 53: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/53.jpg)
![Page 54: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/54.jpg)
![Page 55: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/55.jpg)
![Page 56: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/56.jpg)
Spiral CT
![Page 57: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/57.jpg)
Before
After
![Page 58: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/58.jpg)
Tomographic scan showing infarcted left lung, large clot in right main pulmonary artery
![Page 59: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/59.jpg)
Gadolinium-enhanced magnetic resonance angiography (MRA) is far less sensitive than CT for the detection of PE.
However, unlike chest CT or catheter-based pulmonary angiography, MRA does not require ionizing radiation or injection of iodinated contrast agent.
In addition, magnetic resonance pulmonary angiography can assess right ventricular size and function.
Three-dimensional MRA can be carried out during a single breath-hold and may provide high resolution from the main pulmonary artery through the segmental pulmonary artery branches.
Magnetic Resonance Imaging
![Page 60: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/60.jpg)
![Page 61: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/61.jpg)
MRA with contrast
![Page 62: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/62.jpg)
MRA Real Time
![Page 63: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/63.jpg)
Gold Standard.Positive angiogram provides 100% certainty
that an obstruction exists in the pulmonary artery.
Negative angiogram provides > 90% certainty in the exclusion of PE.
However, pulmonary angiography is required when interventions are planned, such as suction catheter embolectomy, mechanical clot fragmentation, or catheter-directed thrombolysis.
“Court of Last Resort”
Pulmonary angiogram
![Page 64: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/64.jpg)
Pulmonary angiogram
Left-sided pulmonary angiogram showing extensive filling defects
within the left pulmonary artery and its branches.
![Page 65: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/65.jpg)
65
Pulmonary angiogram
![Page 66: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/66.jpg)
This modality generally has limited accuracy in the diagnosis.
The overall sensitivity and specificity for diagnosis of central and peripheral pulmonary embolism by ECHO is 59% and 77%.
It may allow diagnosis of other conditions that may be confused with pulmonary embolism.
Used after diagnosis of PE to stratify the risk of the patient which may aid in treatment.
Used for follow up of residual pulmonary hypertension 2 weeks after the acute event (CTEPH).
Echocardiography
![Page 67: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/67.jpg)
RV enlargement or hypokinesis especially free wall hypokinesis,with sparing of the apex (the McConnell sign) The most specific sign
Interventricular septal flattening and paradoxical motion toward the LV, resulting in a “D-shaped” LV in cross section.
Tricuspid regurgitation, reduced RV systolic function(TAPSE > 16mm)
Direct visualization of the thrombus in the pulmonary arteries or RV or RA (In transit PE)
Dilated IVC , lost normal respiratory collapse
ECHO signs of PE
![Page 68: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/68.jpg)
Before
After
![Page 69: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/69.jpg)
Present the 2 videos in the folder
ECHO Videos
![Page 70: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/70.jpg)
No validated clinical decision rulesNo consensus in evidence for diagnostic
imaging algorithmBalance risk of radiation vs. risk of missed
fatal diagnosis or unnecessary anticoagulation
MDCT delivers higher radiation dose to mother but lower dose to fetus than V/Q scanning
Consider low-dose CT-PA or reduced-dose lung scintigraphy
Imaging in Pregnancy
![Page 71: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/71.jpg)
Plain chest radiograph – Usually normal and non-specific signs.
Radionuclide ventilation-perfusion lung scan – Excellent negative predictive value.
CT Angiography of the pulmonary arteries – Quickly becoming method of choice.
Pulmonary angiography – Gold standard but invasive.
Imaging-nut shell
![Page 72: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/72.jpg)
WBC Poor sensitivity and nonspecific
Can be as high as 20,000 in some patients
Hgb/Hct PTE does not alter count but if extreme,
consider polycythemia, a known risk factor
ESR Don’t get one, terrible test in regard to any
predictive value
Ancillary Test
![Page 73: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/73.jpg)
Fibrin split product ( reflect plasmin’s breakdownOf fibrin Endogenous but ineffective Fibrinolysis) Quantitative test have 80-85% sensitivity, and 93-100%
negative predictive value
High negative predictive value in non hospitalized patients
False Positives:
Pregnant PatientsPost-partum < 1 weekMalignancySurgery within 1 week
Advanced age > 80 yearsSepsisHemmorrhageCVA
AMICollagen Vascular DiseasesHepatic Impairment
D-dimer Test
![Page 74: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/74.jpg)
D-dimer
QualitativeBed side RBC agglutination test
“SimpliRED D-dimer”
QuantitativeEnzyme linked immunosorbent asssay “Dimertest”Positive assay is > 500ng/ml VIDAS D-dimer, 2nd generation ELISA test
Diagnostic Testing
![Page 75: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/75.jpg)
ABG has a limited role.It usually reveal hypoxemia, hypocapnia and
respiratory alkalosis.
ABG analysis
![Page 76: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/76.jpg)
The electrocardiogram (ECG) helps exclude acute myocardial infarction.
T wave inversion in leads V1 to V4 has the greatest accuracy for identification of right ventricular dysfunction in patients with acute PE.
Electrocardiographic manifestations of right-sided heart strain ,which is an ominous prognostic finding.
Electrocardiogram (ECG)
![Page 77: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/77.jpg)
Sinus tachycardia:8-73%P Pulmonale : 6-33%Rightward axis shift : 3-66%Inverted T-waves in >/= right chest leads: 50%S1Q3T3 pattern: 11-50% (S1-60%, Q3-53% ,T3-
20%)Clockwise rotation:10-56%RBBB (complete/incomplete): 6-67%AF or A flutter: 0-35%No ECG changes: 20-24%
ECG Signs of PE
![Page 78: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/78.jpg)
Electrocardiogram from a 33-year-old man who presented with a left main pulmonary artery embolism on chest CT scan. He was hemodynamically stable and had normal right ventricular function on echocardiography. His troponin and brain natriuretic peptide levels were normal. He was managed with anticoagulation alone. On the initial electrocardiogram, he has a heart rate of 90/min, S1Q3T3, and incomplete right bundle branch block, with inverted or flattened T waves in leads V1 through V4 .
![Page 79: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/79.jpg)
![Page 80: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/80.jpg)
![Page 81: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/81.jpg)
S1 Q3 T3 Pattern
![Page 82: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/82.jpg)
Rt. Bundle Branch Block
![Page 83: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/83.jpg)
Rt. Ventricular Strain
![Page 84: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/84.jpg)
BNP & NT- Pro BNPcTroponin T & IH-FABP (Heart type)Growth differentiation factor -15
Biomarkers for detecting myocardial injury
![Page 85: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/85.jpg)
Prognostic Value of Troponins in AcutePulmonary Embolism
![Page 86: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/86.jpg)
Conclusion: Elevated troponin levels were associated with a high risk of (early) death resulting from pulmonary embolism (OR, 9.44; 95% CI, 4.14 to 21.49)
These findings identify troponin as a promising tool for rapid risk stratification of patients with pulmonary embolism.
![Page 87: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/87.jpg)
Typically greater in patients with PE.Sensitivity of 60% and specificity of 62%.At a threshold of 500 pg/mL, the sensitivity of
pro-BNP for predicting adverse events was 95%, and the specificity was 57%.
BNP & pro-BNP
![Page 88: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/88.jpg)
Doppler ultrasound of leg veins
Principle - Veins are normally compressible; Presence of DVT renders
veins non-compressible50% of patients with PE have positive
ultrasound(95% of PE are due to leg DVT)
![Page 89: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/89.jpg)
![Page 90: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/90.jpg)
Oxygen saturation Nonspecific, but suspect PE if there is a sudden, otherwise unexplained decrement
D-dimer An excellent “rule-out” test if normal, especially if accompanied by non–high clinical probability
Electrocardiography May suggest an alternative diagnosis, such as myocardial infarction or pericarditis
Lung scanning Usually provides ambiguous result; used in lieu of chest CT for patients with anaphylaxis to contrast agent, renal
insufficiency, or pregnancy
Chest CT The most accurate diagnostic imaging test for PE ; beware if CT result and clinical likelihood probability are
discordant
Pulmonary angiography Invasive, costly, uncomfortable; used primarily when local catheter intervention is planned
Echocardiography Best used as a prognostic test in patients with established PE rather than as a diagnostic test ; many
patients with large PE will have normal echocardiograms
Venous ultrasonography Excellent for diagnosis of acute symptomatic proximal DVT; a normal study does not rule out PE because a
recent leg DVT may have embolized completely; calf vein imaging is operator dependent
Magnetic resonance Reliable only for imaging of proximal segmental pulmonary arteries; requires gadolinium but does not
require iodinated contrast agent
Diagnostic Tests for Suspected Pulmonary Embolism
![Page 91: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/91.jpg)
No consensus on who to testIncreased likelihood if:
Age <50 years without immediate identifiable risk factors (idiopathic or unprovoked)
Family historyRecurrent clotsIf clot is in an unusual site (portal, hepatic,
mesenteric, cerebral)Unprovoked upper extremity clot (no catheter,
no surgeries)Patients with warfarin-induced skin necrosis
(they may have protein C deficiency)
Hypercoagulability work-up
![Page 92: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/92.jpg)
Protein C or S deficiencyFactor V leiden deficiencyAnti-thrombin III deficiencyProthrombin gene mutationAntiphospholipid antibodyHigh HomocysteineThe most common cause of congenital hyper-coagulability is protein C resistance due to factor V
Leiden mutation
Hypercoagulability work-up )cont’d(
![Page 93: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/93.jpg)
Differential Diagnosis
![Page 94: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/94.jpg)
PneumothoraxMyocardial ischemiaPericarditisAsthmaPneumoniaMI with cardiogenic shockCardiac tamponadeAortic dissection
![Page 95: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/95.jpg)
Treatment
![Page 96: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/96.jpg)
Pre test probability Risk stratification
Approach to the patient of PE
![Page 97: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/97.jpg)
Pre test probability Risk stratification
Approach to the patient of PE
![Page 98: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/98.jpg)
Definition: “The probability of the target disorder (PE) before a diagnostic test result is known”.
Used to decide how to proceed with diagnostic testing and final disposition
How do we work up?- Pretest Probability
![Page 99: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/99.jpg)
SCORE POINTSDVT symptoms or signs 3
An alternative diagnosis is less likely than PE
3
Heart rate >100/min 1.5Immobilization or
surgery within 4 weeks1.5
Prior DVT or PE 1.5Hemoptysis 1Malignancy
(on treatment, treated in the past 6 months,
palliative)
1
Classic Wells Criteria to Assess Clinical Likelihood of Pulmonary
Embolism
>4 score points = high probability ≤4 score points = non–high probability
![Page 100: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/100.jpg)
DVT symptoms or signs 1
An alternative diagnosis is less likely than PE
1
Heart rate >100/min 1
Immobilization or surgery within 4 weeks
1
Prior DVT or PE 1
Hemoptysis 1
Cancer treated within 6 months or metastatic
1
Simplified Wells Criteria to Assess Clinical Likelihood of Pulmonary Embolism
>1 score point = high probability
≤1 score point = non–high probability
![Page 101: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/101.jpg)
Original Geneva score
![Page 102: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/102.jpg)
Revised Geneva score
![Page 103: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/103.jpg)
Pre test probability Risk stratification
Approach to the patient of PE
![Page 104: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/104.jpg)
MassiveSubmassiveLow-Risk PEPulmonary infarction syndrome
ACC/AHA Classification
![Page 105: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/105.jpg)
Acute PE with sustained hypotension (systolic blood pressure 90 mm Hg for at least 15 minutes or requiring inotropic support, not due to a cause other than PE, such as
Arrhythmia Hypovolemia Sepsis Left ventricular (LV) dysfunction Pulselessness Persistent profound bradycardia (heart rate 40
bpm with signs or symptoms of shock)
Massive PE
![Page 106: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/106.jpg)
Acute PE without systemic hypotension (systolic blood pressure 90mm Hg) but with either RV dysfunction or myocardial necrosis
RV dysfunction means the presence of at least 1 of the following
RV dilation (apical 4-chamber RV diameter divided by LV diameter 0.9) or RV systolic dysfunction on echocardiography
RV dilation (4-chamber RV diameter divided by LV diameter 0.9) on CT
Electrocardiographic changes (new complete or incomplete right bundle-branch block, anteroseptal ST elevation or depression, or anteroseptal T-wave inversion)
Elevation of BNP (90 pg/mL) Elevation of N-terminal pro-BNP (500 pg/mL) myocardial necrosis means the presence of at least 1 of the
following Elevation of troponin or H-FABP
Submassive PE
![Page 107: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/107.jpg)
Acute PE and the absence of the clinical markers of adverse prognosis that define massive or submassive PE
Low-Risk PE
![Page 108: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/108.jpg)
Caused by a tiny peripheral pulmonary embolism
Pleuritic chest pain, often not responsive to narcotics
Low-grade fever Leukocytosis Pleural rub Occasional scant hemoptysis
Pulmonary Infarction Syndrome
![Page 109: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/109.jpg)
![Page 110: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/110.jpg)
![Page 111: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/111.jpg)
![Page 112: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/112.jpg)
Goals: Prevent death from a current embolic
event
Reduce the likelihood of recurrent embolic events
Minimize the long-term morbidity of the event
Treatment:
![Page 113: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/113.jpg)
Oxygen inhalation up to ventillatory supportAnticoagulationInferior vena cava filterAdditional options for massive PEThrombolytic agentCatheter embolectomySurgical embolectomyHaemodynamic support - inotropes
Treatment options for pulmonary emboli
![Page 114: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/114.jpg)
Begin treatment with either unfractionated heparin or LMWH, then switch to warfarin (Prevents additional thrombus formation and permits endogenous fibrinolytic mechanisms to lyse clot that has already been formed, Does NOT directly dissolve thrombus that already exists)
It is important that a patient should be anticoagulated with heparin before initiating warfarin therapy
Target INR is 2 – 3
Treatment-Anticoagulation
![Page 115: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/115.jpg)
80 units/kg bolus (minimum, 5000 units; maximum, 10,000 units) followed by a continuous infusion of 18 units/kg/h ) maximum 1000 units/h)
aPTT monitoring is required
I/V UF Heparin
![Page 116: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/116.jpg)
Intravenous Unfractionated Heparin “Raschke Nomogram”
![Page 117: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/117.jpg)
Subcutaneous UFH: aPTT monitoring15,000 units or 17,500 units every 12 h
(initial dose for patients weighing 50–70 kg and >70 kg, respectively)
Subcutaneous UFH: no aPTT monitoring 330 units/kg bolus then 250 units/kg every 12
h
Subcutaneous UFH
![Page 118: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/118.jpg)
LMWH
![Page 119: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/119.jpg)
![Page 120: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/120.jpg)
![Page 121: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/121.jpg)
Anticoagulant pentasaccharide that specifically inhibits activated factor X
By selectively binding to antithrombin, fondaparinux potentiates (about 300 times) the neutralization of factor Xa by antithrombin
Fondaparinux does not cross-react with heparin-induced antibodies
FDA has approved fondaparinux for initial treatment of acute PE and acute DVT as a bridge to oral anticoagulation with warfarin
Fondaparinux
![Page 122: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/122.jpg)
![Page 123: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/123.jpg)
![Page 124: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/124.jpg)
Use of Heparin Before and After Thrombolysis
![Page 125: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/125.jpg)
![Page 126: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/126.jpg)
Oral anticoagulants: Warfarin
![Page 127: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/127.jpg)
127
Important drug interactions with warfarin
Drugs that decrease warfarin requirement
Drugs that increase warfarin requirement
Phenylbutazone BarbituratesMetronidazole CarbamazepineTrimethoprim-sulfamethoxazole RifampinAmiodarone PenicillinSecond- and third-generation cephalosporins
Griseofulvin
Clofibrate CholestyramineErythromycinAnabolic steroidsThyroxine
![Page 128: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/128.jpg)
128
Dosage and monitoring of anticoagulant therapy
Dosage and monitoring of anticoagulant therapyAfter initiating heparin therapy, repeat APTT every 6 h for first 24 h and then every 24 h when therapeutic APTT is achievedWarfarin 5 mg/d can be started on day 1 of therapy; there is no benefit from higher starting dosesPlatelet count should be monitored at least every 3 d during initial heparin therapyTherapeutic APTT should correspond to plasma heparin level of 0.2–0.4 IU/mLHeparin is usually continued for 5–7 dHeparin can be stopped after 4–5 d of warfarin therapy when INR is in 2.0–3.0 range
![Page 129: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/129.jpg)
![Page 130: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/130.jpg)
Promise immediate onset of action and administration in fixed doses without routine laboratory coagulation monitoring
These drugs have few drug-drug or drug-food interactions, making them more “user friendly”
Dabigatran is a direct thrombin inhibitor Rivaroxaban is a factor Xa inhibitor Both are approved in Canada and Europe for
VTE prevention after knee or hip arthroplasty
Novel Anticoagulants
![Page 131: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/131.jpg)
![Page 132: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/132.jpg)
![Page 133: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/133.jpg)
![Page 134: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/134.jpg)
![Page 135: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/135.jpg)
![Page 136: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/136.jpg)
Optimal Duration of Anticoagulation
![Page 137: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/137.jpg)
![Page 138: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/138.jpg)
Thrombolysis 1. Hemodynamically compromised by PE –
definitie indication 2. Right ventricular dysfunction (strain)
detected by echocardiography (better), positive troponin.
Treatment (cont)-- Thrombolysis
![Page 139: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/139.jpg)
THROMBOLYSIS FOR PE
![Page 140: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/140.jpg)
Massive or major PE: Thrombolytic therapy is indicated
Submassive (non-massive) PE: Thrombolytic therapy may be indicated in the presence of RV dysfunction
AGREEMENT AND CONTROVERSY
![Page 141: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/141.jpg)
![Page 142: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/142.jpg)
![Page 143: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/143.jpg)
Thrombolytic agents
![Page 144: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/144.jpg)
At present, the alteplase regimen in which 100 mg is administered intravenously over two hours is the most rapidly administered protocol that is currently approved for use in the United States
![Page 145: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/145.jpg)
These should be particularly scrutinized if lytic therapy is
considered
CONTRAINDICATIONS
![Page 146: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/146.jpg)
Intravenous route -- primary method of delivery Rapid infusion -- Shorter regimens may not only prove efficacious but also reduce the risk of hemorrhagic complications Catheter-directed therapy -- for massive PE, may induce major bleeding
About administration
![Page 147: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/147.jpg)
Potential benefits include More rapid resolution of symptoms (eg, dyspnea,
chest pain, and psychological distress) Stabilization of respiratory and cardiovascular
function without need for mechanical ventilation or vasopressor support
Reduction of RV damage Improved exercise tolerance Prevention of PE recurrence Increased probability of survival
Potential Benefits and Harm
![Page 148: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/148.jpg)
Potential harm includes Disabling or fatal hemorrhage including
intracerebral hemorrhage Increased risk of minor hemorrhage,
resulting in prolongation of hospitalization and need for blood product replacement
![Page 149: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/149.jpg)
Performed as an alternative to thrombolysis When there are contraindications When emergency surgical thrombectomy is unavailable
or contraindicated Hybrid therapy that includes both catheter-based clot
fragmentation and local thrombolysis is an emerging strategy
Goals of catheter-based therapy include Rapidly reducing pulmonary artery pressure, RV strain,
and pulmonary vascular resistance (PVR) Increasing systemic perfusion Facilitating RV recovery
Catheter-Based Interventions
![Page 150: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/150.jpg)
3 general categories of percutaneous intervention
Aspiration thrombectomyThrombus fragmentationRheolytic thrombectomy
![Page 151: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/151.jpg)
The Greenfield embolectomy catheterBalloon angioplasty and stentsPigtail rotational catheterAmplatz thrombectomy device (ATD)Hydrodynamic thrombectomy catheter
devicesAspirex pulmonary embolism
thrombectomy catheter
VARIOUS DEVICES
![Page 152: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/152.jpg)
When contraindications preclude thrombolysis
Surgical excision of a right atrial thrombus Rescue patients whose condition is
refractory to thrombolysisOlder case series suggest a mortality rate
between 20% and 30%In a more recent study, 47 patients
underwent surgical embolectomy in a 4-year period, with a 96% survival rate
Surgical Embolectomy
![Page 153: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/153.jpg)
![Page 154: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/154.jpg)
![Page 155: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/155.jpg)
PREPIC Trial randomized 400 patients with proximal DVT at high risk for PE
IVC filters significantly reduced the incidence of recurrent PE at 12 days (1.1% versus 4.8%, P0.03) and at 8 years (6.2% versus 15.1%, P0.008)
IVC filters were associated with an increased incidence of recurrent DVT at 2 years (20.8% versus 11.6%, P0.02) (act as a nidus)
Inferior Vena Cava Filters
![Page 156: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/156.jpg)
![Page 157: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/157.jpg)
![Page 158: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/158.jpg)
Various inferior vena caval filters- A Greenfield filter
B Titanium Greenfield filter C Simon-Nitinol filter
D LGM or Vena Tech filter E Amplatz filter
F Bird’s Nest filterG Günther filter
(Adapted from Becker et al).
![Page 159: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/159.jpg)
Early complications Device malposition
(1.3%)Pneumothorax(0.02
%),Hematoma (0.6%)Air embolism (0.2%)Inadvertent carotid
artery puncture (0.04%)
Arteriovenous fistula (0.02%)
Recurrent DVT (21%)
IVC thrombosis (2% to 10%) ,
IVC penetration (0.3%)
Filter migration (0.3%)
Complications associated with IVC filter
Late complications
![Page 160: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/160.jpg)
Recommendations on IVC Filters in the Setting of Acute PE
![Page 161: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/161.jpg)
![Page 162: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/162.jpg)
![Page 163: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/163.jpg)
![Page 164: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/164.jpg)
Mechanical:Leg elevationGraded compression stockingEarly ambulationPneumatic compression boot
Prophylaxis of VTE
![Page 165: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/165.jpg)
Pharmacological:Un-fractionated heparin (UFH): given every 8 hours SCLow-molecular weight heparin: Enoxaparin 30-40mg SC every 24 hoursFondaparinux: 2.5mg SC every 24 hoursDesirudin: A recombinant direct thrombin inhibitor. Dose: 15mg SC every 12 hoursRivaroxaban: A novel oral anti-Xa agent. Dose: 10mg every 24 hours
![Page 166: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/166.jpg)
Inferior vena cava (IVC) filter:Considered as secondary prophylaxis or secondary prevention against PE but not DVT.IVC filter is indicated in patients with high risk of recurrence when other methods are contra-indicated (Class IIb, LOE B).The routine use of IVC filters is not recommended (Class III, LOE B).
![Page 167: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/167.jpg)
Acute heart failure
![Page 168: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/168.jpg)
Unfractionated heparin 5000 units SC bid or tid or
Enoxaparin 40 mg SC qd or
Dalteparin 2500 or 5000 units SC qd
Before surgeryGeneral surgery
![Page 169: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/169.jpg)
Unfractionated heparin 5000 units SC bid or
Enoxaparin 40 mg SC qd and
Graduated compression stockings or intermittent pneumatic compression
Consider surveillance lower extremity ultrasonography
Neurosurgery
![Page 170: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/170.jpg)
Oncologic surgery Enoxaparin 40 mg SC qd Thoracic surgery Unfractionated heparin
5000 units SC tid and Graduated compression stockings or intermittent pneumatic compression
![Page 171: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/171.jpg)
Septic embolism- drug addicts, catheters & pacemaker wires, septic thrombophlebitis
Intravascular foreign bodies- broken catheters, guidewires,vena cava filters
Fat embolism- traumaVenous air embolismAmniotic fluid embolism- occur in 1/8000 –
1/80,000, high maternal & fetal mortalityTalc embolism
Non-thrombotic pulmonary embolism
![Page 172: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/172.jpg)
Pulmonary embolism in pregnancy
![Page 173: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/173.jpg)
![Page 174: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/174.jpg)
No validated clinical decision rulesNo consensus in evidence for diagnostic
imaging algorithmBalance risk of radiation vs. risk of missed
fatal diagnosis or unnecessary anticoagulation
MDCT delivers higher radiation dose to mother but lower dose to fetus than V/Q scanning
Consider low-dose CT-PA or reduced-dose lung scintigraphy
Imaging in Pregnancy
![Page 175: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/175.jpg)
V/Q scan should be the first imaging modality
Thrombolysis carries high bleeding risk, but should be used in critical cases
Anticoagulation: Heparin should be used in the 1st-12th w., after 36th w., but warfarin should be used in 13th-36th w.
Anicoagulation should extend to 3 months after delivery
![Page 176: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/176.jpg)
Prognosis
![Page 177: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/177.jpg)
![Page 178: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/178.jpg)
ICOPER DATA
![Page 179: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/179.jpg)
Hemodynamic instability
Right ventricular hypokinesis on echocardiogram
Right ventricular enlargement on echocardiogram or chest CT scan
Right ventricular strain on electrocardiogram
Elevated cardiac biomarkers
Predictors of Increased Mortality
![Page 180: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/180.jpg)
Home Message
![Page 181: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/181.jpg)
Pulmonary Emboli remain a potentially deadly and common event which may present in various ways
Don't’ be fooled if your patient lacks the “classic” signs and symptoms!
Consider PE in any patient with an unexplainable cause of dyspnea, pleuritic chest pain, or findings of tachycardia, tachpnea, or hypoxemia
2nd Generation Qualitative D-Dimers have NPV of 93-99%
Heparin remains the mainstay of therapy with the initiation of Warfarin to follow
Simplified Algorithm: ( Pretest probability, D-Dimer, +/- CT angio), then risk stratification and treatment)
ConclusionSummary Points
![Page 182: Pulmonary embolism@ghanem@.2013](https://reader037.fdocuments.in/reader037/viewer/2022102322/55497bbfb4c9056e598b5b28/html5/thumbnails/182.jpg)
THANK YOU